NanoViricides Inc Share Price OTC Bulletin Board
Equities
US6300871042
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
|
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 24.34M 1.88B |
---|---|---|---|---|---|
Net income 2024 * | -8M -617M | Net income 2025 * | -14M -1.08B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-2.82
x | P/E ratio 2025 * |
-1.86
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.69% |
Managers | Title | Age | Since |
---|---|---|---|
Anil Diwan
CEO | Chief Executive Officer | 66 | 31/03/05 |
Meeta Vyas
DFI | Director of Finance/CFO | 66 | 12/05/13 |
Jayant Tatake
CTO | Chief Tech/Sci/R&D Officer | - | 02/03/10 |
Members of the board | Title | Age | Since |
---|---|---|---|
Brian Zucker
BRD | Director/Board Member | 62 | 12/11/20 |
Anil Diwan
CEO | Chief Executive Officer | 66 | 31/03/05 |
Director/Board Member | 73 | 06/02/20 |
1st Jan change | Capi. | |
---|---|---|
+20.17% | 127B | |
+24.67% | 117B | |
+25.44% | 27.67B | |
-17.74% | 20.33B | |
-15.17% | 16.79B | |
-15.21% | 15.63B | |
+11.91% | 14.84B | |
-47.10% | 14.65B | |
+54.50% | 14.43B |